170 related articles for article (PubMed ID: 35917013)
1. Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma.
Sonal S; Deshpande V; Ting DT; Cusack JC; Parikh AR; Neyaz A; Pankaj A; Taylor MS; Dinaux AM; Leijssen LGJ; Boudreau C; Locascio JJ; Kunitake H; Goldstone RN; Bordeianou LG; Cauley CE; Ricciardi R; Berger DL
Ann Surg Oncol; 2022 Nov; 29(12):7372-7382. PubMed ID: 35917013
[TBL] [Abstract][Full Text] [Related]
2. Immunological and Clinico-Molecular Features of Tumor Border Configuration in Colorectal Cancer.
Sonal S; Deshpande V; Ting DT; Neyaz A; Pankaj A; Taylor MS; Dinaux AM; Leijssen LG; Boudreau C; Berger DL
J Am Coll Surg; 2023 Jan; 236(1):126-134. PubMed ID: 36519916
[TBL] [Abstract][Full Text] [Related]
3. Incidence of extramural venous invasion in colorectal carcinoma as determined at the invasive tumor front and its prognostic impact.
Dirschmid K; Sterlacci W; Wöll E; Tschann P; Rhomberg M; Offner F
Hum Pathol; 2019 Apr; 86():102-107. PubMed ID: 30571994
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Extramural Venous Invasion in Colorectal Cancer: A Detailed Analysis Based on Tumor Location and Evaluation Methods.
Shin YM; Pyo JS; Park MJ
Int J Surg Pathol; 2020 Apr; 28(2):120-127. PubMed ID: 31544653
[TBL] [Abstract][Full Text] [Related]
5. Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death.
Mc Entee PD; Shokuhi P; Rogers AC; Mehigan BJ; McCormick PH; Gillham CM; Kennedy MJ; Gallagher DJ; Ryan CE; Muldoon CB; Larkin JO
Eur J Surg Oncol; 2022 Jul; 48(7):1638-1642. PubMed ID: 35249791
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer.
Chand M; Evans J; Swift RI; Tekkis PP; West NP; Stamp G; Heald RJ; Brown G
Ann Surg; 2015 Mar; 261(3):473-9. PubMed ID: 25243543
[TBL] [Abstract][Full Text] [Related]
7. [The importance of pre-operative MRI-detected extramural vascular invasion in the treatment of rectal carcinoma].
Hemmelová B; Bohatá Š; Kyclová J; Kala Z; Penka I
Rozhl Chir; 2018; 97(4):172-175. PubMed ID: 29726263
[TBL] [Abstract][Full Text] [Related]
8. Persistent extramural vascular invasion positivity on magnetic resonance imaging after neoadjuvant chemoradiotherapy predicts poor outcome in rectal cancer.
Guner OS; Tumay LV
Asian J Surg; 2021 Jun; 44(6):841-847. PubMed ID: 33573925
[TBL] [Abstract][Full Text] [Related]
9. Double Negativity of MRI-Detected and Pathologically-Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
Sakanaka T; Iwamoto H; Matsuda K; Mitani Y; Nakamura Y; Murakami D; Takemoto N; Tamiya M; Hyo T; Matsuzaki I; Kinoshita Y; Nagai H; Ikoma A; Iwamoto R; Takahashi Y; Kojima F; Murata SI; Sonomura T; Kawai M
Ann Surg Oncol; 2024 Apr; 31(4):2425-2438. PubMed ID: 38253948
[TBL] [Abstract][Full Text] [Related]
10. Identification and Prognostic Effect of Extramural Venous Invasion in Locally Advanced Esophageal Squamous Cell Carcinoma.
Lin Z; Plukker JTM; Tian DP; Chen SB; Kats-Ugurlu G; Su M
Am J Surg Pathol; 2023 Jul; 47(7):766-773. PubMed ID: 37199448
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of MRI-detected extramural venous invasion in rectal carcinoma.
Bugg WG; Andreou AK; Biswas D; Toms AP; Williams SM
Clin Radiol; 2014 Jun; 69(6):619-23. PubMed ID: 24581964
[TBL] [Abstract][Full Text] [Related]
12. MRI Detection of Extramural Venous Invasion in Rectal Cancer: Correlation With Histopathology Using Elastin Stain.
Jhaveri KS; Hosseini-Nik H; Thipphavong S; Assarzadegan N; Menezes RJ; Kennedy ED; Kirsch R
AJR Am J Roentgenol; 2016 Apr; 206(4):747-55. PubMed ID: 26933769
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Chemotherapy Benefits on Patients with Extramural Vascular Invasion in Stages II and III Colon Cancer.
Qwaider YZ; Sell NM; Stafford CE; Kunitake H; Ricciardi R; Bordeianou LG; Deshpande V; Goldstone RN; Cauley CE; Berger DL
J Gastrointest Surg; 2021 Aug; 25(8):2019-2025. PubMed ID: 33009639
[TBL] [Abstract][Full Text] [Related]
14. DNA hypermethylation as a predictor of extramural vascular invasion (EMVI) in rectal cancer.
Kokelaar RF; Jones HG; Williamson J; Williams N; Griffiths AP; Beynon J; Jenkins GJ; Harris DA
Cancer Biol Ther; 2018 Mar; 19(3):214-221. PubMed ID: 29260978
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion.
Prampolini F; Taschini S; Pecchi A; Sani F; Spallanzani A; Gelsomino F; Kaleci S; Torricelli P
Abdom Radiol (NY); 2020 Oct; 45(10):2941-2949. PubMed ID: 30483843
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of extramural vascular invasion in T4 rectal cancer.
Bhangu A; Fitzgerald JE; Slesser A; Northover JM; Faiz O; Tekkis P
Colorectal Dis; 2013 Nov; 15(11):e665-71. PubMed ID: 24103008
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Study of Extramural Venous Invasion in Colorectal Cancer.
McClelland D; Murray GI
PLoS One; 2015; 10(12):e0144987. PubMed ID: 26671331
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance.
Lee ES; Kim MJ; Park SC; Hur BY; Hyun JH; Chang HJ; Baek JY; Kim SY; Kim DY; Oh JH
Eur Radiol; 2018 Feb; 28(2):496-505. PubMed ID: 28786006
[TBL] [Abstract][Full Text] [Related]
19. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
20. Immune microenvironment and lymph node yield in colorectal cancer.
Lee SH; Pankaj A; Neyaz A; Ono Y; Rickelt S; Ferrone C; Ting D; Patil DT; Yilmaz O; Berger D; Deshpande V; Yılmaz O
Br J Cancer; 2023 Oct; 129(6):917-924. PubMed ID: 37507544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
